-transparent.png){kind=logo}
A distinct increase of kallikrein content in blood plasma of patients with nephrotic syndrome as well as activation of thrombin simultaneously with a decrease in the prothrombin level were recorded in samples with synthetic chromogenic substrates S-2160 (Bz-Phe-Val-Arg-pNa), S-2238 (D-Phe-Pip-Arg-pNA) and S-2302 (D-Pro-Phe-Arg-pNA). Limited proteolysis of prothrombin by blood plasma kallikrein appears to be among the possible reasons of thrombin activation in the patients with nephrotic syndrome. Activity of plasmin, measured with S-2251 (D-Val-Leu-Lys-pNA) as a chromogenic substrate, was practically unlatered in blood plasma of these patients.
Related Publications
I P Baskova, and
T S Paskhina, and
L R Poliantseva, and
R I Iakubovskaia, and
A Tiero
January 1979,
Advances in experimental medicine and biology,
I P Baskova, and
T S Paskhina, and
L R Poliantseva, and
R I Iakubovskaia, and
A Tiero
January 1982,
Scandinavian journal of clinical and laboratory investigation. Supplementum,
I P Baskova, and
T S Paskhina, and
L R Poliantseva, and
R I Iakubovskaia, and
A Tiero
January 1989,
Nephron,
I P Baskova, and
T S Paskhina, and
L R Poliantseva, and
R I Iakubovskaia, and
A Tiero
June 1984,
Pediatriia,
I P Baskova, and
T S Paskhina, and
L R Poliantseva, and
R I Iakubovskaia, and
A Tiero
August 1989,
Vrachebnoe delo,
I P Baskova, and
T S Paskhina, and
L R Poliantseva, and
R I Iakubovskaia, and
A Tiero
October 1984,
Klinicheskaia meditsina,
I P Baskova, and
T S Paskhina, and
L R Poliantseva, and
R I Iakubovskaia, and
A Tiero
February 1979,
Das Medizinische Laboratorium,
I P Baskova, and
T S Paskhina, and
L R Poliantseva, and
R I Iakubovskaia, and
A Tiero
July 1980,
Klinicheskaia meditsina,
I P Baskova, and
T S Paskhina, and
L R Poliantseva, and
R I Iakubovskaia, and
A Tiero
January 1981,
Terapevticheskii arkhiv,
I P Baskova, and
T S Paskhina, and
L R Poliantseva, and
R I Iakubovskaia, and
A Tiero
January 1981,
Terapevticheskii arkhiv,
